Rahul Guptan

Partner, London

Biography

Overview

Rahul Guptan is a partner in the Firm's capital markets group based in Singapore. Rahul has more than 25 years of experience advising on complex cross-border India related transactions and specialises in securities and corporate law with a special focus on capital markets transactions. He is dual qualified in England and Wales and India.

Rahul regularly advises underwriters and issuers on various equity and debt capital markets offerings pursuant to Rule 144A and Regulation S, including IPOs, qualified institutional placements (QIP), high yield bond and convertible bond issuances, MTN programs, as well as tender offer and share buybacks.

Rahul has a formidable reputation in the India financing market. He was recognized as a leading lawyer for Singapore Capital Markets: International and India Capital Markets: International in Chambers Asia Pacific 2023-2024 and Chambers Global 2023-2024; ranked as a Leading Individual for Singapore Capital Markets: Foreign firms in Asia Pacific Legal 500 2023-2024; and listed as a Highly Regarded Singapore capital markets practitioner in IFLR1000 2023-2024.

He was ranked as a Recommended Lawyer for Capital Markets in Lexology Index's (formerly Who's Who Legal) Southeast Asia Guide 2024 and included as one of the Singapore Debt & Equity leading practitioners in Who's Who Capital Markets Report 2022. He was also included in the International A List 2019-2024 by India Business Law Journal, as well as being recognized as one of the Singapore's 70 most influential lawyers aged 40 and under by Singapore Business Review 2016.

Bars and Courts
England and Wales, Solicitor
Bar Council of Maharashtra & Goa, India
Education
BA, LLB (Hons)
National Law School of India University
Languages
English
Hindi

Experience

Rahul's experience includes advising:

  • The book running lead managers in relation to the IPO of Niva Bupa Health Insurance Company Limited, one of India's largest and fastest growing standalone retail health insurers, and the only health insurance company in India that is majority controlled by a foreign global healthcare group, Bupa.
  • The book running lead managers on Hyundai Motor India Limited's Rule 144A/Regulation S IPO, which is the largest in Indian history, the world's second-largest IPO in 2024 to date and Hyundai Motor's first listing outside Korea.
  • The book running lead managers in relation to the proposed Rule 144A/Regulation S IPO of Schloss Bangalore Limited, a Brookfield-sponsored company that owns and operates luxury hotels under The Leela brand.
  • The book running lead managers in relation to the proposed Rule 144A/Regulation S IPO of International Gemological Institute (India) Limited ("IGI India"), a 100% Blackstone-owned portfolio company. IGI India is part of International Gemological Institute, which is the world's second largest independent certification and accreditation services provider by revenue for diamonds, studded jewelry and colored stones.
  • The book running lead managers in the proposed IPO of Carraro India Limited, a manufacturer of axles and transmission systems for agricultural tractors and construction vehicles. Carraro India is a subsidiary of Italy-based Carraro SpA which heads the Carraro Group.
  • The book running lead managers in relation to the proposed Rule 144A/Regulation S IPO of Rubicon Research Limited, a General Atlantic portfolio company. Rubicon Research is a pharmaceutical formulations company and the only Indian pharmaceutical player with a complete focus on regulated markets.
  • The book running lead managers on the Regulation S IPO of Awfis Space Solutions Limited, the largest flexible workspace solutions company in India.
  • The book running lead managers on the US$360 million IPO of Aadhar Housing Finance Limited, a Blackstone portfolio company focused on the low-income housing segment in India.
  • The book running lead managers on the 144A IPO of Fedbank Financial Services Limited, a retail focused non-banking finance company.The book running lead managers on the US$180 million 144A IPO of Campus Activewear Limited, one of the largest sports and athleisure footwear brand in India. The offering was backed by private equity company TPG Growth III SF Pte. Ltd. and QRG Enterprises Limited.
  • The Carlyle Group's investment entity, CA Swift Investments, as seller, in a block trade of up to 18,404,607 equity shares (with a value of approximately US$75 million) of Delhivery Limited, which is listed on the BSE Limited and National Stock Exchange of India Limited, and is one of the Delivery largest and fastest growing fully integrated logistics player in India.
  • The book running lead managers on the qualified institutions placement of shares of Prestige Estates Projects Limited, one of the leading real estate developers in India, totaling INR 50 billion (approximately US$595.56 million).
  • The book running lead managers on the qualified institutions placement of The Federal Bank Limited aggregating to INR 30,399.92 million (approximately US$370 million).
  • The bookrunning lead managers on the institutional placement of units in the Brookfield India Real Estate Trust aggregating to INR 23,053.59 million (approximately US$279 million). Brookfield India Real Estate Trust is India's first institutionally managed public commercial real estate vehicle and it is sponsored by an affiliate of Brookfield Corporation.
Awards and Recognition

Leading lawyer for Singapore Capital Markets: International by Chambers Asia Pacific 2023-2024

Leading lawyer for India Capital Markets: International by Chambers Asia Pacific 2023-2024

Leading Individual for Singapore Capital Markets: Foreign firms by Asia Pacific Legal 500 2023-2024

Ranked in International A List 2019-2024 by India Business Law Journal

Recommended individual for Capital Markets – Debt & Equity in Who's Who Legal (now Lexology Index) Global Guide 2023

Recommended Lawyer for Capital Markets in Lexology Index (formerly Who’s Who Legal) Southeast Asia 2023-2024

Recognized as one of the Singapore Debt & Equity Leading practitioners by Who’s Who Capital Markets Report 2022

Leading individual for Singapore Capital Markets: Foreign firms by IFLR1000 2021

Among Singapore's 70 most influential lawyers aged 40 and under by Singapore Business Review 2016